| http://www.w3.org/ns/prov#value | - The board is satisfied that this problem has been solved by the claimed subject-matter, i.e. by using a monoclonal antibody or fragment thereof which binds to the alpha4 subunit of the human alpha4beta1 receptor, in view of the technical detail disclosed in the patent in suit.
|
